1. Home
  2. VTSI vs GANX Comparison

VTSI vs GANX Comparison

Compare VTSI & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • GANX
  • Stock Information
  • Founded
  • VTSI 1993
  • GANX 2017
  • Country
  • VTSI United States
  • GANX United States
  • Employees
  • VTSI N/A
  • GANX N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • GANX Health Care
  • Exchange
  • VTSI Nasdaq
  • GANX Nasdaq
  • Market Cap
  • VTSI 60.6M
  • GANX 69.0M
  • IPO Year
  • VTSI N/A
  • GANX 2021
  • Fundamental
  • Price
  • VTSI $5.35
  • GANX $1.58
  • Analyst Decision
  • VTSI Strong Buy
  • GANX Strong Buy
  • Analyst Count
  • VTSI 1
  • GANX 5
  • Target Price
  • VTSI $7.00
  • GANX $8.20
  • AVG Volume (30 Days)
  • VTSI 39.3K
  • GANX 526.2K
  • Earning Date
  • VTSI 11-11-2025
  • GANX 11-13-2025
  • Dividend Yield
  • VTSI N/A
  • GANX N/A
  • EPS Growth
  • VTSI N/A
  • GANX N/A
  • EPS
  • VTSI 0.10
  • GANX N/A
  • Revenue
  • VTSI $27,068,543.00
  • GANX N/A
  • Revenue This Year
  • VTSI $10.31
  • GANX N/A
  • Revenue Next Year
  • VTSI $12.71
  • GANX N/A
  • P/E Ratio
  • VTSI $54.29
  • GANX N/A
  • Revenue Growth
  • VTSI N/A
  • GANX N/A
  • 52 Week Low
  • VTSI $3.57
  • GANX $1.36
  • 52 Week High
  • VTSI $8.53
  • GANX $3.19
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 37.26
  • GANX 39.85
  • Support Level
  • VTSI $5.51
  • GANX $1.55
  • Resistance Level
  • VTSI $5.82
  • GANX $1.78
  • Average True Range (ATR)
  • VTSI 0.22
  • GANX 0.13
  • MACD
  • VTSI -0.02
  • GANX -0.03
  • Stochastic Oscillator
  • VTSI 1.72
  • GANX 6.00

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: